Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Akshay S. Desai, MD
FINE-HEART Pooled Analysis
Maria Pabon
NYHA FC and Finerenone Response: Clinical Trial Insights
John Ostrominski
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Jonathan Cunningham, MD
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Gautam Nayak, MD
Advances in Care for ATTR-CM: Current and Emerging Strategies
Treating ATTR-CM: Current Strategies and Emerging Options
Frederick Ruberg, MD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Michelle Kittleson, MD, PhD
Understanding the Pathophysiology Behind ATTR-CM
Managing Patients With AAV in the Rheumatology Clinic
Andreas Kronbichler, MD
Bernhard Hellmich, MD
Trade off: Ischemic/Thrombotic vs Bleeding
Renato D. Lopes, MD, MHS, PhD
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Silke R. Brix, MD, MRCP, SCPR
Optimizing AAV Outcomes: Maintenance Therapies
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Elevating Care for Patients With Severe Renal Disease in AAV
Patient Case Study: Obesity
Valeria Caso, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.